Who owns ACADIA PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ACAD from SEC Form 13F filings across 355 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 355 institutions disclosed 168.7M shares of ACADIA PHARMACEUTICALS INC worth $4.27B — about 98.3% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
355
13F holders
$4.27B
value, 2026 filers
98.3%
of shares outstanding (168.7M sh)
54
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ACAD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 42.9M | $1.09B | 5.4% | 25% | 0.0% |
| 2 | BlackRock, Inc. | 22.5M | $569.6M | 0.0% | 13.1% | +4.5% |
| 3 | STATE STREET CORP | 9.1M | $229.6M | 0.0% | 5.3% | +8.9% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.8M | $223.6M | 0.0% | 5.2% | +1.9% |
| 5 | RTW INVESTMENTS, LP | 7.1M | $180.8M | 1.5% | 4.2% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 5.8M | $145.8M | 0.0% | 3.4% | +1.8% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 3.7M | $93.5M | 0.0% | 2.2% | +17.1% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 3.4M | $85.0M | 0.0% | 2% | -3.1% |
| 9 | Palo Alto Investors LP | 2.9M | $72.5M | 10.0% | 1.7% | -0.3% |
| 10 | GOLDMAN SACHS GROUP INC | 2.6M | $65.3M | 0.0% | 1.5% | +65.6% |
| 11 | Qube Research & Technologies Ltd | 2.4M | $61.9M | 0.1% | 1.4% | +157.5% |
| 12 | Point72 Asset Management, L.P. | 2.4M | $61.6M | 0.1% | 1.4% | -5.6% |
| 13 | CITADEL ADVISORS LLC | 2.2M | $55.2M | 0.0% | 1.3% | +250.4% |
| 14 | Pictet Asset Management Holding SA | 2.0M | $50.1M | 0.0% | 1.2% | -2.1% |
| 15 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.0M | $49.8M | 0.0% | 1.1% | +25.5% |
| 16 | MARSHALL WACE, LLP | 1.8M | $44.7M | 0.0% | 1% | +2216.5% |
| 17 | D. E. Shaw & Co., Inc. | 1.7M | $43.0M | 0.0% | 1% | +132.6% |
| 18 | BRAIDWELL LP | 1.6M | $41.7M | 1.5% | 1% | -33.4% |
| 19 | NORGES BANKNEW | 1.6M | $41.1M | 0.0% | 0.9% | new |
| 20 | Frazier Life Sciences Management, L.P. | 1.4M | $36.4M | 0.8% | 0.8% | 0.0% |
| 21 | NORTHERN TRUST CORP | 1.4M | $34.6M | 0.0% | 0.8% | +7.5% |
| 22 | Nuveen, LLC | 1.3M | $34.1M | 0.0% | 0.8% | +30.0% |
| 23 | Artisan Partners Limited Partnership | 1.3M | $33.5M | 0.1% | 0.8% | -0.5% |
| 24 | BANK OF AMERICA CORP /DE/ | 1.3M | $32.9M | 0.0% | 0.8% | -16.3% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 1.3M | $32.4M | 0.0% | 0.7% | -25.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.